Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Ribosome dysfunction underlies SLFN14-related thrombocytopenia

Fabienne Ver Donck, Kato Ramaekers, Chantal Thys, Christine Van Laer, Kathelijne Peerlinck, Chris Van Geet, Koji Eto, Veerle Labarque, Kathleen Freson

Blood (2023) 141 (18): 2261–2274.

https://doi.org/10.1182/blood.2022017712

Published: 2023

Includes: Supplemental data

Journal Articles

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding

Blood (2017) 130 (8): 1026–1030.

https://doi.org/10.1182/blood-2017-03-776773

Published: 2017

Includes: Supplemental data

Journal Articles

A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss

Blood (2016) 127 (23): 2903–2914.

https://doi.org/10.1182/blood-2015-10-675629

Published: 2016

Includes: Supplemental data

Journal Articles

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura

Hendrik B. Feys, Inge Pareyn, Renee Vancraenenbroeck, Marc De Maeyer, Hans Deckmyn, Chris Van Geet, Karen Vanhoorelbeke

Blood (2009) 114 (21): 4749–4752.

https://doi.org/10.1182/blood-2009-07-230615

Published: 2009

Journal Articles

PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications

Kathleen Freson, Karen Peeters, Rita De Vos, Christine Wittevrongel, Chantal Thys, Marc F. Hoylaerts, Jos Vermylen, Chris Van Geet

Blood (2008) 111 (4): 1885–1893.

https://doi.org/10.1182/blood-2007-06-098558

Published: 2008

Includes: Supplemental data

Journal Articles

Inhibition of VPAC1 Signaling Raises Platelet Numbers after Myelosuppressive Therapy and in GATA1 Congenital Thrombocytopenia.

Karen Peeters, Kathleen Freson, PhD, Christine Wittevrongel, Chantal Thys, Jean-Marie Stassen, PhD, Marc F. Hoylaerts, PhD, Chris Van Geet, MD PhD

Blood (2007) 110 (11): 1264.

https://doi.org/10.1182/blood.V110.11.1264.1264

Published: 2007

Journal Articles

Increased Bleeding Tendency in a Patient with Caffey Disease Due to a COL1A1 Mutation and a Defect in Platelet Morphology and Function.

Kathleen Freson, PhD, Veerle Labarque, MD, Chantal Thys, Christine Wittevrongel, Rita De Vos, MD, PhD, Richard Farndale, PhD, Chris Van Geet, MD, PhD

Blood (2005) 106 (11): 736.

https://doi.org/10.1182/blood.V106.11.736.736

Published: 2005

Journal Articles

The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure

Kathleen Freson, Rita De Vos, Christine Wittevrongel, Chantal Thys, Johan Defoor, Luc Vanhees, Jos Vermylen, Kathelijne Peerlinck, Chris Van Geet

Blood (2005) 106 (7): 2356–2362.

https://doi.org/10.1182/blood-2005-02-0723

Published: 2005

Includes: Supplemental data

Journal Articles

Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience

Béatrice Gulbis, David Haberman, Dominique Dufour, Catherine Christophe, Christiane Vermylen, Faustin Kagambega, Francis Corazza, Christine Devalck, Marie-Françoise Dresse, Kathleen Hunninck, Axel Klein, Phu Quoc Le, Michèle Loop, Philip Maes, Pierre Philippet, Eric Sariban, Chris Van Geet, Alina Ferster

Blood (2005) 105 (7): 2685–2690.

https://doi.org/10.1182/blood-2004-07-2704

Published: 2005

Journal Articles

VPAC1 Receptor-Mediated Regulation of Megakaryopoiesis.

Kathleen Freson, PhD, Chantal Thys, Christine Wittevrongel, Rita De Vos, PhD, Jos Vermylen, PhD, MD, Marc F. Hoylaerts, PhD, MD, Chris Van Geet, PhD, MD

Blood (2004) 104 (11): 735.

https://doi.org/10.1182/blood.V104.11.735.735

Published: 2004

Journal Articles

Myelodysplastic Syndrome Due to Somatic GATA1 Mutation.

Kathleen Freson, PhD, Paresh Vyas, PhD, MD, Chantal Thys, Christine Wittevrongel, Rita De Vos, PhD, Chris Van Geet, PhD, MD

Blood (2004) 104 (11): 4711.

https://doi.org/10.1182/blood.V104.11.4711.4711

Published: 2004

Journal Articles

Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation

Kathleen Freson, Koen Devriendt, Gert Matthijs, Achiel Van Hoof, Rita De Vos, Chantal Thys, Kristien Minner, Marc F. Hoylaerts, Jos Vermylen, Chris Van Geet

Blood (2001) 98 (1): 85–92.

https://doi.org/10.1182/blood.V98.1.85

Published: 2001

Journal Articles

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

Alina Ferster, Parvine Tahriri, Christiane Vermylen, Geneviève Sturbois, Francis Corazza, Pierre Fondu, Christine Devalck, Marie F. Dresse, Walter Feremans, Kathleen Hunninck, Michele Toppet, Pierre Philippet, Chris Van Geet, Eric Sariban

Blood (2001) 97 (11): 3628–3632.

https://doi.org/10.1182/blood.V97.11.3628

Published: 2001

NARROW

Ribosome dysfunction underlies SLFN14-related thrombocytopenia

Expanded repertoire of RASGRP2 variants responsible for platelet dysfunction and severe bleeding

A gain-of-function variant in DIAPH1 causes dominant macrothrombocytopenia and hearing loss

Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura

PACAP and its receptor VPAC1 regulate megakaryocyte maturation: therapeutic implications

Inhibition of VPAC1 Signaling Raises Platelet Numbers after Myelosuppressive Therapy and in GATA1 Congenital Thrombocytopenia.

Increased Bleeding Tendency in a Patient with Caffey Disease Due to a COL1A1 Mutation and a Defect in Platelet Morphology and Function.

The TUBB1 Q43P functional polymorphism reduces the risk of cardiovascular disease in men by modulating platelet function and structure

Hydroxyurea for sickle cell disease in children and for prevention of cerebrovascular events: the Belgian experience

VPAC1 Receptor-Mediated Regulation of Megakaryopoiesis.

Myelodysplastic Syndrome Due to Somatic GATA1 Mutation.

Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation

Five years of experience with hydroxyurea in children and young adults with sickle cell disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only